News

Atomic-level mapping of amorphous diabetes drug reveals hydrogen bonds as key to stability
Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...
Xenon signals Phase 3 epilepsy readout in early 2026 with expanded pipeline advancements
Guidance for the X-TOLE2 Phase 3 epilepsy study shifted from the second half of 2025 to "early next year," reflecting a slight timeline delay. Management's strategic focus remains on advancing ...
US Medicare lays out timeline for third round of drug price negotiations
The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...
Fortrea CEO Resigns as Ongoing Macro Headwinds Continue to Affect Near Term
Product governance is a key ESG risk for Fortrea and the rest of the CRO industry. CROs must ensure that trials meet strict quality and safety standards from a variety of regulatory entities. Fortrea ...
Industry experts say AI is revolutionizing drug discovery, promising faster, cheaper cures
The healthcare and medical industries are increasingly integrating artificial intelligence into their operations, ...
DMR News on MSN2d
OpenAI and FDA explore AI for speeding up drug evaluations
OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...